Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Povidone-Iodine Rinses for Biofilm-associated Chronic Rhinosinusitis
NCT04097613Phase 1Completed
- Sponsor
- St. Paul's Hospital
- Start
- Jul 2017
- Primary completion
- Apr 2019
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of IVIEW-1502 in chronic rhinosinusitis (CRS), sponsored by St. Paul's Hospital. Primary endpoint: Modified Lund-Kennedy Endoscopic Score at 6 weeks. Started Jul 2017; status: completed.
02
Drugs
IVIEW-1502
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT04097613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04097613.